MOLINA HEALTHCARE, INC. - Common Stock, $0.001 Par Value (MOH)

CUSIP: 60855R100

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Common Stock, $0.001 Par Value
Total 13F shares
53,143,939
Total 13F value
$15,814,934,813
Holder snapshot 6 visible 7 signals
Share change
-155,480
Put/Call ratio
111%
SEC-reported price per share
$297.90
Number of holders
618
Value change
-$59,517,797
Number of buys
322
Open additional details 1 more signal available
Number of sells
313
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
52,061,691

Security key

60855R100

Report period

Q2 2025

Institutions

618

Top holders

10

MOH full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 MOLINA HEALTHCARE, INC. SEC filings MOLINA HEALTHCARE, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MOH - MOLINA HEALTHCARE, INC. - Common Stock, $0.001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital Research Global I...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F 13D/G Lead comparable stake: 4% 13D/G row: Capital Research Global Investors Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.
Comparable ownership Top 5
Capital Research Global Investors 4%
VANGUARD GROUP INC 12%
Capital World Investors 10%
BlackRock, Inc. 8.9%
PRICE T ROWE ASSOCIATES INC /MD/ 7.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital Research Global Investors
13F 13D/G
Company
13F 13D/G
4%
from 13D/G
$954,285,243
2,897,220 shares
 — 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13F
12%
$2,135,323,707
6,482,661 shares
 — 31 Mar 2025
Capital World Investors
13F
Company
13F
10%
$1,743,122,539
5,291,978 shares
 — 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
8.9%
$1,531,997,337
4,651,013 shares
 — 31 Mar 2025
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
7.4%
$1,264,214,000
3,838,043 shares
 — 31 Mar 2025
FMR LLC
13F
Company
13F
5.1%
$873,278,016
2,651,198 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
618
Shares
53,143,939
Rows available
618
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
612
Q2 2025 holders
618
Holder diff
6
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .